ClinicalTrials.Veeva

Menu

Proximal Medial Gastriocnemius Recession for Chronic Plantar Fasciitis

O

Ostfold Hospital Trust

Status

Active, not recruiting

Conditions

Chronic Plantar Fasciitis

Treatments

Procedure: Proximal Medial Gastrocnemius Recession

Study type

Interventional

Funder types

Other

Identifiers

NCT05162144
REK317597

Details and patient eligibility

About

This prospective kohort study will follow 150 patients treated with proximal medial gastrocnemius recession for plantar fasciitts. Follow up time is two years and the main outcome is the Manchester Oxford Foot Questionnaire.

A regression analasys will be performed to identify possible patient baseline factors that may affect the effect of surgery,

Full description

Recent studies indicate that chronic plantar fasciitis can be treated effectively with Proximal Medial Gastrocnemius Recession (PMGR). In our hospital this treatment has been inocorporated into routine care. This prospective kohort study will follow 150 patients with chronic planatar fasciitis operated with PMGR study. The follow up time is 2 years and the study aims at documenting the effect of the surgery with PROMS (patient related outcome measures), MRI (magnetic resonnance imaging) and ankle movement measurements. 26 patient-related baseline factors will also be registered. A regression analysis will be performed to identify factors that may be predictive to the effect of PMGR surgery.

Enrollment

150 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age 18-75 years.
  2. Diagnosis plantar fasciitis verified clinically by orthopaedic surgeon.
  3. Diagnosis verified by MRI. MRI criteria: Thickening of the plantar fascia, oedema in the calcaneus, pathological singal changes in the plantar fascia (37)
  4. Duration of symptoms must be at least 12 months.
  5. An isolated gastrocnemius contracture must be verified with the Silverskiölds test before inclusion.
  6. Conventional Physical Therapy must have been tried at least three months without positive effects on symptoms from affected foot.

Exclusion criteria

  1. Previously undergone surgery for plantar fasciitis.
  2. Patients with severe talocrural pathology or serious malalignment of foot and ankle
  3. Severely reduced peripheral circulation or chronic ulcerations of the foot
  4. History of alcoholism, drug abuse, psychological or other emotional problems likely to jeopardize informed consent.
  5. Patients with a contraindication/non-compliance for MRI examination.
  6. Unable to walk without aid.
  7. Not able to read and/or speak a Scandinavian language or English adequately.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

150 participants in 1 patient group

Proximal Medial Gastrocnemius Recession Surgery
Experimental group
Description:
All patients included in the Cohort Study will recieve this PMGR-surgery
Treatment:
Procedure: Proximal Medial Gastrocnemius Recession

Trial contacts and locations

1

Loading...

Central trial contact

Marius Molund, MD PhD; Martin O Riiser, MD Phd candidate

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems